ID
29858
Description
Study ID: 104864-201 Clinical Study ID: 104864/A201 Study Title: A Phase III, Open-Label, Multicenter, Randomized, Comparative Study of Topotecan, Ara-C and G-CSF (TAG) versus Idarubicin, Ara-C and G-CSF (IDAG) in MDS Patients with RAEB (High-Risk), RAEB-t or in Patients with AML from a Preceding Phase of MDS Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: topotecan Trade Name: hycamtin Study Indication: Myelodysplastic Syndrome https://www.gsk-clinicalstudyregister.com/study/104864/201?search=study&#rs
Lien
https://www.gsk-clinicalstudyregister.com/study/104864/201?search=study&#rs
Mots-clés
Versions (1)
- 24/04/2018 24/04/2018 - Halim Ugurlu
Détendeur de droits
GSK
Téléchargé le
24 avril 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
GSK Study ID 104864-201 Supportive Therapies-Transfusions, Anti-Infectives and Concominant Medication
Supportive Therapies-Transfusions, Anti-Infectives and Concominant Medication
Description
Supportive Therapy Transfusion
Alias
- UMLS CUI-1
- C1879316
- UMLS CUI-2
- C0014822
- UMLS CUI-3
- C0436313
Description
If Yes to Supportive Therapy (Including Erythropoietin)
Alias
- UMLS CUI-1
- C1879316
- UMLS CUI-2
- C0014822
- UMLS CUI-3
- C0436313
Description
Type of transfusions
Type de données
text
Alias
- UMLS CUI [1,1]
- C1879316
- UMLS CUI [1,2]
- C0332307
Description
Transfusions (Number of Units)
Type de données
text
Alias
- UMLS CUI [1,1]
- C1879316
- UMLS CUI [1,2]
- C0237753
Description
Erythropoietin Dose
Type de données
float
Unités de mesure
- units/kg
Alias
- UMLS CUI [1,1]
- C0014822
- UMLS CUI [1,2]
- C3174092
Description
Date
Type de données
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1879316
Description
Supportive Anti-Infective Therapy
Alias
- UMLS CUI-1
- C1141958
- UMLS CUI-2
- C0436313
Description
If Yes to Supportive Anti-Infective Therapy
Alias
- UMLS CUI-1
- C1141958
- UMLS CUI-2
- C0436313
Description
If a treatment is recorded here, do not record on the Concomitant Medication section.
Type de données
text
Alias
- UMLS CUI [1]
- C2360065
Description
Total Daily Dose
Type de données
text
Alias
- UMLS CUI [1]
- C2348070
Description
For Route, see general instructions for acceptable abbreviations.
Type de données
text
Alias
- UMLS CUI [1]
- C0013153
Description
Where appropriate, medical conditions should be recorded in the Adverse Experiences section, utilizing the same terminology.
Type de données
text
Alias
- UMLS CUI [1]
- C3843040
Description
Record PM for anti-infectives administered prophylactically, EM for anti-infectives used for symptomatic treatment, and TX for anti-infectives administered for a confirmed infection in the column provided.
Type de données
text
Alias
- UMLS CUI [1]
- C1141958
Description
Start Date
Type de données
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C3174092
Description
End Date
Type de données
date
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C3174092
Description
If Continuing to Medication
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0549178
Description
Concominant Medication
Alias
- UMLS CUI-1
- C2347852
Description
Record all concomitant medication taken during this course. Record PM for prophylactic treatment with Medical Condition for prophylactically administered medications. If a medication was marked 'Continuing' at the initial visit, it must be recorded below. Where appropriate, medical conditions should be recorded on the Adverse Experience Form, utilizing the same terminology
Type de données
text
Alias
- UMLS CUI [1,1]
- C2360065
- UMLS CUI [1,2]
- C2347852
Description
Total Daily Dose
Type de données
text
Alias
- UMLS CUI [1]
- C2348070
Description
For Route, see General Instructions for acceptable abbreviations
Type de données
text
Alias
- UMLS CUI [1,1]
- C0013153
- UMLS CUI [1,2]
- C2347852
Description
Medical Condition
Type de données
text
Alias
- UMLS CUI [1]
- C3843040
Description
Start Date
Type de données
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C2347852
Description
End Date
Type de données
date
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C2347852
Description
If Continung to Medication
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0549178
Similar models
Supportive Therapies-Transfusions, Anti-Infectives and Concominant Medication
C0014822 (UMLS CUI-2)
C0436313 (UMLS CUI-3)
C0014822 (UMLS CUI [1,2])
C0436313 (UMLS CUI [1,3])
C0014822 (UMLS CUI-2)
C0436313 (UMLS CUI-3)
C0332307 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C3174092 (UMLS CUI [1,2])
C1879316 (UMLS CUI [1,2])
C0436313 (UMLS CUI-2)
C1514463 (UMLS CUI [1,2])
C1521721 (UMLS CUI [1,3])
C0436313 (UMLS CUI-2)
C3174092 (UMLS CUI [1,2])
C3174092 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])